DUBLIN–(BUSINESS WIRE)–The “Type 2 Diabetes Treatment: Global Market Outlook” report has been added to ResearchAndMarkets.com’s offering.
In this report, the market has been segmented based on route of administration, therapy type and region. The report provides an overview of the global type 2 diabetes treatment market and analyses market trends. Using 2021 as the base year, it provides estimated market data for the forecast period of 2022 to 2027. Revenue forecasts for this period are segmented based on route of administration, therapy type and geography. Market values have been estimated based on the total revenue of type 2 diabetes therapies providers.
The report covers the market for type 2 diabetes treatment with regard to the therapy type across different regions. It also highlights major trends and challenges that affect the market and the vendor landscape. It estimates the global market for type 2 diabetes treatment in 2021, and then provides projections for the expected market size through 2027.
The scope of the study includes the various types of medicines involved in type 2 diabetes treatment and management. Blood glucose monitoring, diagnostic systems and devices, and insulin-delivery devices used in the treatment of type 2 diabetes, however, have been excluded from this study.
Report Includes
Key Topics Covered:
Chapter 1 Market Outlook
1.1 Market Snapshot
Chapter 2 Executive Summary
Chapter 3 Market Overview
3.1 Type 2 Diabetes Overview
3.1.1 What is Type 2 Diabetes?
3.1.2 Prevalence and Epidemiology of Type 2 Diabetes
3.1.3 Diagnosing Type 2 Diabetes
3.1.4 Treatment for Type 2 Diabetes
3.2 Market Drivers
3.2.1 Rising Prevalence of Diabetes
3.2.2 Next Generation of Type 2 Diabetes Treatment
3.2.3 High Unmet Need
3.2.4 Premium Pricing
3.2.5 Collaborations and Licensing Agreements
3.3 Market Challenge
3.3.1 Loss of Exclusivity, Genericization and Pricing Pressure
3.3.2 Evolving Regulatory Scenario
3.4 Impact of Covid-19
Chapter 4 Emerging Trends and Opportunities
4.1 Patient Outcomes Beyond Glucose Control
4.2 Diabetes Technology With Digital Health
4.3 Growing Trend Toward Oral Antidiabetics
4.4 Growing Focus on Accessibility and Affordability of Medicine
Chapter 5 Market Breakdown by Route of Administration and Therapy Type
5.1 Type 2 Diabetes Treatment Market by Route of Administration
5.1.1 Market Size and Forecast
5.2 Injectable Therapies Market by Type
5.2.1 Insulin Therapy
5.2.2 Glucagon-Like Peptide 1 Therapy
5.2.3 Market Size and Forecast
5.3 Oral Medications Market by Drug Class
5.3.1 Dipeptidyl Peptidase-4 Inhibitors
5.3.2 Sodium-Glucose Cotransporter-2 Inhibitors
5.3.3 Glucagon-Like Peptide 1 Receptor Agonists
5.3.4 Other Oral Antidiabetic Medications
5.3.5 Market Size and Forecast
5.4 Type 2 Diabetes Treatment Market by Therapy Type
5.4.1 Market Size and Forecast
5.5 Insulin Therapy Market by Insulin Type
5.5.1 Market Size and Forecast
5.6 Non-Insulin Therapies Market by Drug Type
5.6.1 Market Size and Forecast
Chapter 6 Market Breakdown by Region
6.1 Type 2 Diabetes Treatment Market Size by Region
6.2 North America
6.3 Europe
6.4 Asia-Pacific
6.5 Rest of the World
Chapter 7 Competitive Landscape
7.1 Global Market Shares of Leading Companies
7.2 Recent Key Developments
7.3 Blockbuster Diabetes Drug and Therapy Revenue
7.4 Facing the Patent Cliff
Chapter 8 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/ehijup-2-diabetes?w=4
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900